Pharmaco Vigilance Africa

The Eswatini kick-off meeting of the PAVIA project took place between 25th June and 29th June 2018. The Ministry of Health of Eswatini was hosting the event in the Royal Swazi Spa Resort

This report summarizes the key discussions and action points from the kick-off meeting. • The objectives of PAVIA and its operational structure • Identified challenges • Priorities and main action points singled out during the meetings.

The meeting was important forum for implementer’s of both projects to launch the programs in the country and discuss on baseline assessment and implementation of the project to strengthen the national capacity in monitoring medicine safety.

The meeting was important forum for implementer’s of both projects to launch the programs in the country and discuss on baseline assessment and implementation of the project to strengthen the national capacity in monitoring medicine safety.

The meeting was important forum for implementer’s of both projects to launch the programs in the country and discuss on baseline assessment and implementation of the project to strengthen the national capacity in monitoring medicine safety.

The meeting was important forum for implementer’s of both projects to launch the programs in the country and discuss on baseline assessment and implementation of the project to strengthen the national capacity in monitoring medicine safety.

Frank Cobelens and Henry Tumwinyukye visited NEPAD in June to look for opportunities for collaboration. It was a very fruitful meeting in which plans were made for the future.

The workshop was being held on March 14 and 15/2019 at Global Hotel, Addis Ababa, Ethiopia. Attendees were representatives from: The national Pharmacovigilance Center, The research Institute, WHO- Ethiopia, Regional Health Bureau, Market Authorization Holders, Professional Association, Healthcare facilities, Non- governmental Partners working on TB, University, PROFORMA Project.
Objectives of the Workshop were:
• To share the findings of the Baseline Assessment conducted jointly by the PAVIA and PROFORMA Projects.
• To enrich the draft pharmacovigilance roadmap that intends to propose country specific solutions for gaps identified on the national pharmacovigilance system.